{"nct_id":"NCT06820463","title":"A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-04-24","start_date_type":"ACTUAL","primary_completion_date":"2028-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-04","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}